IBO
What one share of Impact BioMedical holds
Pharmaceutical Preparations
“We”, “IBO”), discovers, confirms, and patents unique science and technologies which can be developed into new offerings in human healthcare and wellness in collaboration with external partners through licensing, co-development, joint ventures, and other relationships.
Impact BioMedical’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.00 |
|---|---|
| Profit | $0.01 |
| Cash and investments | $0.00 |
| Book value | $0.10 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2022 | $0.00 | −$0.10 | — | −$0.03 | — | $0.42 |
| 2023 | — | −$0.07 | — | −$0.05 | — | — |
| 2024 | — | −$2.30 | — | −$0.27 | — | $0.37 |
| 2025 | $0.00 | −$0.38 | — | −$0.06 | — | $0.12 |